Sanegene Bio
Marc Abrams currently serves as a Scientific Advisory Board Member for Switch Therapeutics and Sanegene Bio, while also holding the position of Chief Scientific Officer at Carbon Biosciences. Previously, Marc was a Senior Vice President of Discovery Research at Dicerna Pharmaceuticals, where involvement in the Executive Leadership Team focused on advancing nucleic acid therapeutics for underserved patients. Marc’s extensive experience in the biopharmaceutical industry includes roles at Merck, where expertise was developed in RNA interference, oncology, and immunology. Marc holds a Ph.D. in Biochemistry from Thomas Jefferson University, an M.S. in Biology from the University of Rochester, and a B.S. in Bioscience & Biotechnology from Drexel University.
This person is not in any teams